4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001649094-24-000076
CHIEF OPERATING OFFICER sold 8,000 shares at an average $114.24 ($913,917)
- CHIEF OPERATING OFFICER acquired 8,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wassil Jim CHIEF OPERATING OFFICER | 2024-10-01 | Option exercise 10b5-1 | +8,000 | $2.42 | $19,360 | 208,646 | D |
| Wassil Jim CHIEF OPERATING OFFICER | 2024-10-01 | Sale 10b5-1 | −2,312 | $113.42 | $262,215 | 206,334 | D |
| Wassil Jim CHIEF OPERATING OFFICER | 2024-10-01 | Sale 10b5-1 | −3,349 | $114.32 | $382,841 | 202,985 | D |
| Wassil Jim CHIEF OPERATING OFFICER | 2024-10-01 | Sale 10b5-1 | −2,339 | $114.95 | $268,861 | 200,646 | D |
| Derivatives | |||||||
| Wassil Jim CHIEF OPERATING OFFICER | 2024-10-01 | Option exercise · Stock Option (right to buy) 10b5-1 | −8,000 | 34,638 | D | ||
| Open-market sales · 8,000 sh · avg $114.24 · $913,917 | |||||||
Loading xslF345X05/wk-form4_1727986596.xml…